Lymphocyte Activation Gene 3 Protein Market- Size, Share, Outlook, and Forecast till 2026

Lymphocyte-activation gene 3, also known as LAG-3, is a protein that is has diverse biological effects on the functioning of T cells. This protein was first discovered in 1990. LAG-3 is an immune checkpoint receptor, and is thus used as the target of various drug development programs.

Increasing prevalence of chronic diseases such as cancer and autoimmune diseases such as AIDS are expected to increase the demand for treatment measures. This in turn, is expected to increase demand for lymphocyte-activation gene 3 protein, thus boosting growth of the lymphocyte-activation gene 3 market. Increasing number of pharmaceutical companies are seeking to develop new treatments for cancer and autoimmune disorders is expected to boost growth of the Lymphocyte-activation gene 3 protein market.

Prima BioMed Ltd is a biotechnology company that is engaged in research, development, and commercialization of licensed medical biotechnology. It is also focused on development of immunotherapeutic products. The Company operates through Cancer Immunotherapy segment with its core technologies based on the Lymphocyte-activation gene 3 (LAG-3) immune control mechanism, which is involved in regulation of the T cell immune response.

The lymphocyte-activation gene 3 market is gaining significant traction, owing to increasing research and development activities by various key players in the market.

F-star, a clinical-stage biopharmaceutical company developing novel bispecific antibodies—announced successful dosing of the first patient with FS118 in a Phase I clinical trial. FS118 is a first-in-class bispecific antagonist simultaneously targeting LAG-3 (Lymphocyte-Activation Gene 3) and PD-L1 (Programmed Death-Ligand 1), two immune checkpoint molecules involved in tumor growth through attenuation of immune surveillance. FS118 showed potent anti-cancer activity in preclinical models, as recently presented by F-star at the 2018 AACR meeting.

In March 2015, a breakthrough in immunotherapy was recorded when the FDA approved Nivolumab as a second line treatment for metastatic lung squamous carcinoma. Nivolumab was previously known to be indicated for use among patients suffering from melanoma that is either not resectable or had not responded to other therapies.6, 7, 8, 10, not all PD‐1 or PD‐L1 positive patients show positive outcomes through this treatment of anti‐PD‐1 or PD‐L1 monoclonal antibody.

In 2014, GSK successfully was able to receive positive outcomes from its product GSK2831781, an anti LAG-3 drug, which proved to demonstrate positive results among healthy people and patients suffering from plaque psoriasis.

Bristol-Myers Squibb, also known as BMS, developed an Anti‐LAG‐3 drug. The company announced in 2017, that it successfully completed its preliminary efficacy trial for BMS-986016—an investigational anti-lymphocyte-activation gene 3 (LAG-3) therapy—in combination with Opdivo (nivolumab) for advanced melanoma. These patients were previously treated with anti-PD-1/PD-L1 therapy, however, showed no progress. While treatment with the new drug helped stop relapse melanoma among these patients. This development in turn, is expected to boost growth of the lymphocyte-activation gene 3 market.

Global Hydrolyzed Whey Protein Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Hydrolyzed Whey Protein in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manuf...

Global Demineralized Whey Protein Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Demineralized Whey Protein in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top ma...

Global Bone Morphogenetic Protein (BMP) Market Professional Survey Report 2017

Published Date : Oct 2017

This report studies Bone Morphogenetic Protein (BMP) in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on ...

Asia-Pacific Wheat Protein (Wheat Gluten) Market Report 2017

Published Date : Oct 2017

In this report, the Asia-Pacific Wheat Protein (Wheat Gluten) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split Asia-Pacific into several key Regions, w...

EMEA (Europe, Middle East and Africa) Protein Supplements Market Report 2017

Published Date : Oct 2017

In this report, the EMEA Protein Supplements market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales ...

Global Soy Protein Isolate Sales Market Report 2017

Published Date : Oct 2017

In this report, the global Soy Protein Isolate market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K MT), rev...

Global Estrogen Receptor Beta Protein Market Research Report 2018

Published Date : Oct 2018

Estrogen Receptor Beta Protein Report by Material, Application, and Geography - Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United...

Global and Chinese Rice protein powder Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Rice protein powder Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Rice protein powder industry with a focus on the Chinese market. The report provides key statistics on the market status of the Rice protein...

Global and Chinese Protein Ingredient Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Protein Ingredient Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Protein Ingredient industry with a focus on the Chinese market. The report provides key statistics on the market status of the Protein Ingred...

Global and Chinese Pea Protein Industry, 2017 Market Research Report

Published Date : Oct 2017

The 'Global and Chinese Pea Protein Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Pea Protein industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pea Protein manufacturers an...

 

Select License :

  • Single User : $4500
  • Multiple User : $7000
  • Corporate User : $10000

Happy To Assist You

Assist you at Worldwide Market Reports

We will be happy to help you find what you need. Please call us or write to us:

Worldwide Market Reports Benefits

Custom Research Solution

Talk to our research consultant to design an exclusive report as per your research needs.

Customer Fulfilment

We aim to fulfil client's research demands with tailored research solutions.

Quick Turnaround Time Reports

We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

360-degree Approach

We cover each industry from supply and demand side with an aim to provide a most holistic research study.